Latest UCLA's Jonsson Comprehensive Cancer Center Stories
PITTSBURGH, April 28, 2011 /PRNewswire/ -- The Oncology Nursing Society (ONS) has joined the Journey Forward collaborative to promote cancer survivorship through the use of Survivorship Care Plans.
ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may be associated with an increased risk of recurrence in women who have had breast cancer, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
BEVERLY HILLS, Calif., March 18, 2011 /PRNewswire/ -- The Jonsson Cancer Center Foundation (JCCF) at UCLA hosts its 16th annual Taste for a Cure Friday, April 15, 2011 at the Beverly Wilshire Hotel.
EVERGREEN PARK, Ill., March 16, 2011 /PRNewswire/ -- Little Company of Mary's Comprehensive Breast Health Center has been granted a three-year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.
A new property of a gene known for its involvement in tumor cell development, growth, and metastasis has been discovered by National Foundation for Cancer Research scientist Paul B. Fisher, M.Ph., Ph.D. and his team at Virginia Commonwealth University.
Three-Year Full Accreditation designated by National Accreditation Program for Breast Centers ZION, Ill., Nov.
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy.
A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, the first such report of a peptide being used to fight malignancies.
BETHESDA, Md., Sept.
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
- The parings of haberdine; also, any kind of fragments.